Universal Health Services (UHS)
(Real Time Quote from BATS)
$182.77 USD
+0.92 (0.51%)
Updated Mar 28, 2024 10:06 AM ET
2-Buy of 5 2
A Value B Growth A Momentum A VGM
Universal Health Services (UHS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$185.64 | $208.00 | $156.00 | 2.08% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Universal Health Services comes to $185.64. The forecasts range from a low of $156.00 to a high of $208.00. The average price target represents an increase of 2.08% from the last closing price of $181.85.
Analyst Price Targets (14)
Broker Rating
Universal Health Services currently has an average brokerage recommendation (ABR) of 2.25 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 16 brokerage firms. The current ABR compares to an ABR of 2.25 a month ago based on 16 recommendations.
Of the 16 recommendations deriving the current ABR, seven are Strong Buy, representing 43.75% of all recommendations. A month ago, Strong Buy represented 43.75%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 8 | 8 | 8 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.25 | 2.25 | 2.25 | 2.20 | 2.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/6/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
2/29/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Sell | Strong Sell |
1/26/2024 | SVB Securities | Whit Mayo | Strong Buy | Strong Buy |
10/26/2023 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.25 |
ABR (Last week) | 2.25 |
# of Recs in ABR | 16 |
Average Target Price | $185.64 |
LT Growth Rate | 15.60% |
Industry | Medical - Hospital |
Industry Rank by ABR | 91 of 252 |
Current Quarter EPS Est: | 3.13 |